Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Hematologists 2018

About Conference

12th World Hematologists Congress will take place in London, UK on March 15-16, 2018. This congress is expected to be the largest and best platform for all the scientists, hematologists, oncologists, pathologists, surgeons, nurses, research scholars, business professionals, students who are working in the field of Hematology.

Theme: Defining a New Outlook and Forefront Research in Hematology

Hematologists 2018 will include speaker talks, brief keynote presentations, workshops and exhibitions, where researchers and associations will exchange ideas and discuss the methodology for new Diagnostics and treatment methods for Hematologic Disorders, Management and Care of Patients, new approaches emerging in Hematology etc.

Prestigious, hematologists, Hematology Oncology educators, postgraduates, affiliations and business meanders will gather under the same rooftop. Hematology Conferences and meetings are planned on the subject " A step towards Excellence in Hematology Research ".

CME Accredited Hematologists 2018 will be organized by ConferenceSeries Ltd which is comprised of 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. ConferenceSeries Ltd  through its international conferences provides an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.

Why to attend?

Conferences share lots of knowledge to Universities, companies. It is advantageous to medical students and researchers furthermore for professors and science laboratory technicians. Conferences additionally benefits and share information between scientist, doctors and delegates. One company networks with different company and that they share information to each other regarding their product at the conference. The companies return to attend conferences and show their exhibit before of eminent members and delegates present at the Conference.

Target Audience

  • Hematologists
  • Oncologists
  • Haematopathologists
  • Scientists
  • Young Researchers
  • Medical Students
  • Physicians/Consultants/ General Practitioners
  • Nurses
  • Residents
  • Directors/Managers
  • Pathologists
  • Presidents & Vice Presidents/ Directors / Administrators
  • Business Entrepreneurs
  • Haematology Pharma Companies
  • Medical Devices Companies
  • Hematology Associations/ Societies

Sessions/Tracks

After the productive venture of series of hematology conferences around the globe ConferenceSeries Ltd  is overwhelmed to welcome all the participants to CME Accrediated “12th World Hematologists Congress” will held on March 15-16, 2018 at London, UK. The CME Accredited conference is going to be organized round the theme "Defining a New Outlook and Forefront Research in Hematology which incorporates prompt keynote presentations, Oral talks, Poster displays and Exhibitions.

CME Accredited Hematologists 2018 is twelfth successive conference of Hematology Conference series that is a global platform to discuss and learn about Hematology, Blood Disorders, Hematologic Oncology, Hematologic Disorders, Immunohematology, Blood Disorders: Diagnosis & Treatment, Clinical and Experimental Hematology, Hematopathology, Pediatric Heamtology, Veterinary Hematology, Hematology Nursing, Stem Cell Research and much more

Track: Hematology

Hematology also spelled as Haematology, is the branch of medicine that came into picture with the study, diagnosis, treatment of diseases associated with the blood and blood components. Hematology involves the study of etiology (Origin of disorder). It includes blood diseases treatment that have an significant effect on the assembly of blood and its components, like blood cells, bone marrow, blood proteins, hemoglobin, blood vessels, platelets, spleen, and also the mechanism of clotting. Physicians specialized in hematology are known as Hematologists or Haematologists. Their conventional work mainly includes the care and treatment of patients with haematological diseases. Hematologists moreover conduct studies in oncology and work with oncologists, specialized in this field are known as Hemato-oncologists and their work is to deal with Cancers related to blood. There are varied hematologic disorders that can affect people. Some of those are bleeding disorders, anemia, hemophilia, general blood clots, etc. As for connected blood cancers such as lymphoma leukemia, and myeloma are also a serious threat. As this a successive conference of CME Accredited Hematology conference series join to have a glimpse of hematology and hematology research at this conference.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy;  Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 58th ASH Annual Meeting & Exposition December 3-6, 2017, San Diego, USA; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Minneapolis, USA; Management Issues in Haematological Disorders in Adults , 21-23 Nov 2017, London, United Kingdom; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; European society of Hematology meetings, British society of hematology conferences, American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Blood Disorders

If anyone is having blood disorder, it can disturb your total health. Because blood is the main fluid of our body. There are many different blood conditions that can affect people such as blood cancers, thrombosis, Anemia, haemophilia, Thalassemia and many more. Mainly blood disorders include, platelets disorders, (White Blood Cell) WBCs disorders, red blood cells (RBCs) disorders such as Anemia, which is the most common among all other blood disorder, according to fact more than three million Americans are affected by Anemia. Sickle cell anemia and Thalassemia are the genetic forms of anaemia. The most common inherited bleeding disorders are Hemophillia and the Von Willebrand disease. Blood disorders furthermore include blood platelets disorders such as: Thrombocytopenia, A condition in which platelets counts of blood decreases, causing a low platelets number in the blood. Thrombosis i.e. formation of a blood clots in blood vessels, which restrict the blood flow through circulatory system. There are much more blood diseases that are going to be discussed in Hematologists 2018

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy;  Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; 7th Blood Cancer Treatment Conference, May 25-27, 2017 London, UK; 12th World Cancer Conference, September 26-28, 2017, London, UK ; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH Meeting on Hematologic Malignancies, September 16-17, 2017, Chicago, USA; ASH Annual Meeting & Exposition December 3-6, 2017, San Diego, USA; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; Management Issues in Haematological Disorders in Adults , 21-23 Nov 2017, London, United Kingdom; European society of Hematology meetings, British society of hematology conferences , American society of hematology meetings and Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Hematologic Oncology

Blood cancer is the mostly spread and most common disorder among other Blood disorders and is a very important aspect of Blood disorder research. So it needs to be cover in discussion of Blood Disorders ConferencesBlood malignancies affect the performance and formation of your blood cells. Cancerous cells restrict your blood from performing its important/regular functions, like prohibiting from serious bleeding or fighting with foreign body/infections agents. A major part of blood based research is going on in this field. Leukaemia mainly affects the white blood cells (WBCs) and are closely linked to the lymphomas and some of them are deeply related to the adult T cells leukaemia, these disorders comes under the lymph proliferative disorders. The cancer which originates from WBCs (white blood cells) is known as lymphoma and this type of disorder is mainly seen in Hodgkin lymphoma these diseases can be treated with hematopoietic stem cell transplantation, radiation therapy and chemotherapy. The bone marrow in which a large number of white blood cells develop that leads to multiple myeloma.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Immunohematology

Immunohematology is known as blood banking as well, is a branch of Hematology which studies antigen-antibody reactions and similar phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. People working in this field are noted to as an immuno-hematologist. Their usual duties include cross-matching, blood typing and antibody identification. This area is dealing with preparing blood, blood components etc. for transfusion and assortment of more compatible components for blood transfusion. People might be immunized to RBCs due to prior exposure to RBCs of other persons, mostly through pregnancy or transfusion. Red blood cells have antigens on them. If a woman is pregnant with a foetus or an individual is transfused with blood that holds antigen which does not match with recipient or mother, this may cause formation of antibodies against blood antigen in the individual. These antibodies may then destroy RBCs which possess the antigen if further transfusions are required. This is why all blood banks go for screening of potential blood recipients for unexpected antibodies and they then select only that blood which lacks offending antigen. The formation of these antibodies is a rare occurrence, approximately 0.1-3% of the general population.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy;  Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 58th ASH Annual Meeting & Exposition December 3-6, 2017, San Diego, USA; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Minneapolis, USA; Management Issues in Haematological Disorders in Adults , 21-23 Nov 2017, London, United Kingdom; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; European society of Hematology meetings, British society of hematology conferences, American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Hematology and oncology

Oncology and Hematology is the diagnosis and treatment of all type of malignancies (cancers) that occur in adults. Treatment includes chemotherapy, radiotherapy, immunotherapy and pathway directed agents etc. Bone marrow transplantation or peripheral stem cell transplantation is also advanced used therapies now days. The Oncology's physicians specialize in all types of cancers including: lymphomas, leukaemia, multiple myeloma, breast, melanoma, lung, gastrointestinal, urologic, brain cancer, and all other types of cancer. Specialists, who are experts in the treatment of patients with blood diseases such as anaemia, bleeding disorders, and clotting problems, are known as Hemato-oncologists. Based on their specialization Hemato-oncologists are subcategorising as the Paediatric Hem/Oncologists, the adult Hem/Oncologists.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy;  Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; 7th Blood Cancer Treatment Conference, May 25-27, 2017 London, UK; 12th World Cancer Conference, September 26-28, 2017, London, UK ; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH Meeting on Hematologic Malignancies, September 16-17, 2017, Chicago, USA; ASH Annual Meeting & Exposition December 3-6, 2017, San Diego, USA; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; Management Issues in Haematological Disorders in Adults , 21-23 Nov 2017, London, United Kingdom; European society of Hematology meetings, British society of hematology conferences , American society of hematology meetings and Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Blood Disorders: Diagnosis & Treatment

After the physical examination, for the detection of blood disorders Physician usually go for Complete blood count (CBC). This is the basic test after that to diagnose a person's blood disorder, the doctor usually must do further blood tests Once a doctor/consultant finds that something is wrong with one or more of the blood cell types, many additional tests are available for further detection of disease. Doctors can measure proportion of the different types of WBCs (white blood cells) and can also determine subtypes of these cells by assessing certain markers on the surface of the cells. Tests are performed to measure the ability of white blood cells to fight foreign body/ infection, to evaluate the functioning of blood platelets and their ability to clot and to check the contents of red blood cells to help determine the cause of anaemia or why the cells are not functioning properly. Most of these tests are done on blood samples, but sometime require a bone marrow sample as well for Bone Marrow Examination. Once the problem is diagnosed Hematologists go for the appropriate treatment for particular problem.  Now a days we have several methods to treat blood cancers such as Chemotherapy, Radiation therapy etc. Now a days advanced technique such as gene therapy is being used to treat Blood disorders. Researchers are attempting to search out ways that to correct the defective genes that cause Blood Disorders. Gene therapy hasn't nonetheless developed to the purpose that it's accepted treatment for Blood Disorder. However, researchers still take a look at gene therapy in clinical trials. Bone Marrow Transplantation, Hematopoietic stem cell therapy and Cord blood transplantation  are new rising varieties of treatment for blood disorders.   

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences , American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Hematopathology

Hematopathology or hemopathology is the subdivision of pathology which studies disorders of hematopoietic cells. Hematopathology is a certified subspecialty, practiced by those physicians who have finished general pathology residency (clinical, anatomic or combined). The Hematopathology department delivers diagnostic services & specialized testing for patients with all types of hematologic disorders. The Hematopathology laboratory offers diagnostic evaluation of blood, lymph nodes, bone marrow, spleen and hematolymphoid lesions in other sites and consist of faculty and staff with expertise in both clinical and anatomic pathology.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences, American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Pediatric Hematology

Pediatric Hematology is a branch of Hematology which deals with the treatment and care of child or teen having Blood Disorder. A paediatric hematologist has the qualifications and experience to evaluate and treat child or teen with Hematologic Disorders. The caring nature to deal with children or teens with blood diseases and blood cancers is learned from progressive training and experience in practice. Pediatric hematologists treat children and teens from birth through young adulthood. Children and teens with blood disorders need special attention than adults. Their bodies are growing and have distinctive medical needs. They normally express their concerns in a different way than adults do. They are not always able to be easy-going and cooperative. Pediatric hematologists know how to examine and treat them in a way to makes them relaxed and cooperative. Even most pediatric hematologists offices are arranged and decorated according to children and teens in mind.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences , American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Veterinary Hematology

Blood tests are done on animals for a variety of reasons. Screening tests, such as a complete blood count (CBC), may be done on clinically normal animals when they are acquired to avoid a financial and/or emotional commitment to a diseased animal, to examine geriatric patients for subclinical disease, or to identify a condition that might make an animal an anesthetic or surgical risk. Screening tests are often done when an ill animal is first examined, especially if systemic signs of illness are present and a specific diagnosis is not apparent from the history and physical examination. Tests may be done to assist in the determination of the severity of a disease, to help formulate a prognosis, and to monitor the response to therapy or progression of disease. Decisions to request hematology tests in animals are largely based on the cost of the test versus the potential benefit of the result to the animal. A CBC is routinely done to establish a database for patient evaluation, while other hematology tests may be done in an attempt to evaluate a specific problem.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

6th  Veterinary Summit, November 14-16, 2017 Atlanta, USA; 7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences, American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Hematology Nursing

Hematology nurses are specially trained to provide nursing care for patients with blood diseases or disorders. They may also assist with blood transfusions, blood tests, research, and chemotherapy. If you go into hematology, expect to have more responsibility than other nurses, prescriptive authority, and the ability to order diagnostic lab work. Some of the more commonly-known blood diseases and disorders a hematology nurse may encounter include: leukemia, lymphoma, sickle cell anaemia and hemophilia. Hematology nurses initiate a plan of care to manage symptoms that result from such blood problems. Hematology nursing is often closely associated with oncology nursing, and some nurses will help patients with pain management if their cancer is particularly aggressive. Hematology nurses may work with adults only or specialize in working only with children i.e. Pediatric Hematology nurses. Their responsibilities include: taking medical histories, performing examinations, starting IVs and working with physicians to diagnose various blood diseases and disorders. Hematology nurses also educate patients and their families on how to live with and manage their blood disease. They may also assist with blood transfusions, blood tests, research and chemotherapy. Advanced practice hematology nursing have some prescriptive authority and can also order diagnostic lab work done.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences , American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Stem Cell Research

Stem cells have the remarkable potential to turn into many different cell types within the body throughout formative years and growth. Additionally, in several tissues they function as a sort of internal repair system, dividing basically without any limit to replenish other cells as long as the person or animal continues to be alive. Once a stem cell divides, each newly developed cell has the potential to stay as a stem cell or become another variety of cell with a more specialised function, like a muscle cell, a red blood corpuscle, or a nerve cell. Stem-cell therapy is the use of stem cells to treat or cure a disease or condition. Bone marrow transplant is the most commonly used stem-cell therapy, however some therapies derived from umbilical cord blood also are in use. A stem cell transplant is a treatment for many forms of cancer. For instance, you might have one if you have leukaemia, myeloma, or some types of lymphoma. Doctors conjointly treat some blood diseases with stem cell transplants.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

8th Cell Research Congress, March 20-22, 2017 Orlando, Florida, USA; 7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences , American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Hematology Market

The global Hematology diagnostics and drugs market is likely to expand from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a five-year compound annual growth rate (CAGR) of 7.5%. A Blood disorder, the chief segment is anticipated to reach nearly $57.3 billion and $80 billion in 2015 and 2020, respectively, representing five-year CAGR of 6.9%. Hematological oncology is the fastest-growing segment, should raise almost $24 billion in 2015 to $38.2 billion in 2020 at a five-year CAGR of 9.7%. Reagents and diagnostics as a segment should reach $6.1 billion in 2020 at a five-year CAGR of 3.2%.

The Americas controlled the largest share of 41.75% of the worldwide Hematology market at a predicted $1,810.4 million in 2013, anticipated to reach $2,479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. Europe holds the second largest Hematology market share. Germany controlled the largest share almost 20% of the European market at an expected $272.8 million in 2013, and is estimated to grasp $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The Asia and Middle East Hematology market is growing in double digits and will remain to grow in the upcoming years. China controlled the largest share of almost 53% of the Asian Hematology market at an expected $216.0 million in 2013, estimated and is to grasp $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018.

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

8th Stem Cell Research Congress, March 20-22, 2017 Orlando, Florida, USA; 7th Blood Cancer Conference, May 25-27, 2017 London, UK; 10th Oncologists Meeting, July 11-13, 2017 Cologne, Germany; Bridging the Gap February 27-28, 2017, 7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences , American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

Track: Case reports and Epidemiology

case report is usually considered a kind of anecdotal proof. Given their intrinsic method limitations, including absence of statistical sampling, case reports are placed at the foot of the hierarchy of clinical proof, beside case series. However, Hematology case reports do have genuinely helpful roles in medical research and evidence-based drugs. Specifically, they need facilitated recognition of recent diseases and adverse effects of treatments. For instance, recognition of the link between administration of teratogen to mothers and malformations in their babies was suggested by the report of a specific case. Case reports have a task in pharmacovigilance. They will additionally facilitate understand the clinical spectrum of rare diseases, moreover as uncommon presentations of common diseases. They can facilitate generate study hypotheses, as well as plausible mechanisms of disease. Case reports might also have a task to play in guiding the personalization of treatments in clinical follow. Therefore it's important to incorporate case reports in Hematologists conferences

Related: CME Accredited | Hematology Conferences | Hematology Conference | Hemotologists Conferences | Hematologic Oncology Conferences | CME Conference Blood Disorders Events | ConferenceSeries Ltd:

7th Blood Cancer Conference, May 25-27, 2017 London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 19th World Cancer Conference, September 26-28, 2017, London, UK; Bone Marrow Transplantation Conference October 17-18, 2017. Rome, Italy; Multiple Myeloma Conference Oct 15-17, 2017 Milano, Italy; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; ASH 3rd International Conference on Multiple Myeloma, October 07-09, 2017, Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2017, China; British Society for Haematology 57th Annual Scientific Meeting, 27 - 29 March, 2017, Brighton; 7th Emirates Haematology Conference 2017 (EHC 2017), March 16-18, 2017, Dubai, UAE;14th Annual Mayo Clinic Hematology Review 2017, January 21, 2017, Estoril, Portugal; European society of Hematology meetings, British society of hematology conferences , American society of hematology meetings  and  Emirates society of hematology annual meeting, ASH Annual MeetingASH ConferencesESH Conference

 

Market Analysis

Glance at Market of Hematology :

According to market study, the total market value of Hematology at present is $15.13 billion. The hematology products segment holds the largest share of the hematology market in 2016. The market value is analysed by 2 segments, namely, hematology reagents and hematology instruments. These two segments had a positive growth till 2013, with a total market value of $4.3 billion, covering $0.6 billion for instruments and $3.6 billion for reagents, and growing at a CAGR of 7.3%. The global market of hematology instruments and reagents, by 2019, is expected to reach $3.13 billion, at CAGR of 5.2% from 2014 to 2019.

The global hematology market is divided into hematology products & services. Hematology products market has been segmented into instruments and consumables. The hematology instruments market is further segmented into analyzers and slide strainers/makers. Whereas, the hematology consumables market has been classified into three major segments namely; regents, stains, and controls and calibrators. Furthermore, based on the end-users, the global hematology market has been segmented into commercial organizations, stand-alone hospitals, research institutes, and clinical testing labs.

The Centers for Medicare & Medicaid Services (CMS) has estimated that the healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2018, at a CAGR of 6.8% for the same period. Europe holds the second largest market. Similarly, in emerging countries, the growing awareness and an increasing middle-class population, with more disposable incomes to spend on healthcare, are the driving factors for the growth of coagulation market.

It is also expected to grow at the highest growth rate by next five years, owing to the increasing development of new hematology reagents. In addition, based on the end-users, the global hematology market has been segmented into commercial organizations, stand-alone hospitals, research institutes, and clinical testing labs. The clinical testing labs hold the largest share of the hematology market in 2017.

A major part of research is going on at the top Universities across the globe, the grants allotted for this research field is around $10.54 billion. Many companies are associated with the blood testing equipment along with various diagnostic instruments, hematologic drugs and other therapeutics, the revenue generated is around $21.1 billion on average by this companies. Besides this various societies and research labs are also associated in this research field.

Past Conference Report

Hematologists 2017

The success of the Hematology conferences has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “7th World Hematologists Congress” during May 08-09, 2017 at Tryp Barcelona Airport, Parque de Negocios Mas Blau II, Plaza Plan Lake, 1-2, 08820 El Prat de Llobregat, Barcelona, ​​Spain. The conference was focused on Hematology & Blood Disorders studies with the theme “A Step towards Excellence in Hematology Research”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like hematology, hematologic oncology, blood disorders, hematologic disorders, oncology, blood disorders diagnosis and treatment etc.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • John Batchelor; Central Manchester Foundation Trust, UK
  • Mingzhi Zhang; First Affiliated Hospital of Zhengzhou University, China
  • Soad KAl Jaouni; King Abdulaziz University, Saudi Arabia
  • Jean-Francois Schved; Montpellier University Hospital, France
  • M Dahmani Fathallah; Arabian Gulf University, Bahrain

Conferenceseries LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries LLC and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Hematologists 2017, Conferenceseries LLC would like to announce the commencement of the “12th World Hematologists Congress” to be held during March 15-16, 2018 at London, UK. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cancer Research.

For More details: http://hematology.conferenceseries.com/europe/

Let us meet again @ Hematologists 2018


Past Reports  Proceedings  Gallery  

Supported By

Journal of Blood Disorders & Transfusion Journal of Blood & Lymph Journal of Hematology & Thromboembolic Diseases

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos

What People Say....

Thank you very much for your excellent organization. I enjoyed the conference and meeting new scientists from all around the world. It is my pleasure and honor having participated to Hematologists 2017.

Speaker

Antonella Bianchi, Università Campus Bio-Medico, Italy

Thank you. I thoroughly enjoyed the conference and it was a great learning opportunity. It was very well organised!

Speaker

Aisha Patel, Gloucestershire NHS Trust, UK